TRIO Pharmaceuticals, Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
TRIO Pharmaceuticals, Inc. is a biotechnology company focused on cancer therapeutics. Based in the San Diego area, the firm aims to improve cancer treatment by developing single-agent therapies that simultaneously address cancer growth and immunosuppression, with a view toward reducing toxicity and treatment costs compared with traditional combination regimens. The company targets patients who have not fully benefited from immune checkpoint therapies, offering an approach intended for those with resistance or low expression of PD-1, PD-L1, or CTLA-4. With a team experienced in cancer drug discovery and development, TRIO Pharmaceuticals positions itself within biotechnology research by pursuing innovative immunotherapeutic strategies distinct from the current standard of care. The organization has public indications of activity and collaboration within the broader biotechnology ecosystem, including involvement from a Purdue-affiliated background and recent external interest in its work.
1-888-653-2347 
support@leadiq.com 
